Stay updated on Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/version change rather than a change to the clinical study details.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedSite revision badge updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision label updated to v3.4.3. The previous version was v3.4.2.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page shows a new site revision label Revision: v3.4.2 and removes older notices (v3.4.1 and the funding-lapse notice). This appears to be a routine site maintenance update without affecting the study content or available actions.SummaryDifference0.5%

- Check80 days agoChange DetectedThe page now shows a government funding notice at the top and the page revision has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page.